1,138 results on '"Galetta, Domenico"'
Search Results
2. Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
3. Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrence
4. The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
5. Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
6. Transfer learning approach in pre-treatment CT images to predict therapeutic response in advanced malignant pleural mesothelioma.
7. Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients
8. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go
9. Exploring the role of respiratory microbiome in lung cancer: A systematic review
10. Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended Thymic Epithelial Tumors
11. Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
12. Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center
13. The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
14. Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
15. DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation
16. EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy
17. ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
18. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy
19. Anastomosis Complications after Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center
20. Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution
21. Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
22. Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
23. The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
24. Tobacco control in Europe: A review of campaign strategies for teenagers and adults
25. Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
26. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives
27. BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.
28. Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival
29. Cancer, Heart Diseases, and Common Risk Factors: Smoke
30. Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer
31. Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy
32. Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study
33. Editorial: Recent advances in surgical management of NSCLC.
34. Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
35. Robotic-assisted thymectomy for early-stage thymoma: a propensity-score matched analysis
36. Robotic-assisted tracheal resection for adenoid cystic carcinoma with extracorporeal membrane oxygenation support
37. Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non–Small-cell Lung Cancer: A Multicenter Italian Survey
38. Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non–Small-cell Lung Cancer: A Systematic Review and Meta-analysis
39. Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non–Small Cell Lung Cancer With a PD-L1 Expression ≥50%
40. Superior Vena Cava Resection
41. Advances in Lung Cancer Therapy
42. A CT-based transfer learning approach to predict NSCLC recurrence: The added-value of peritumoral region
43. Small pleural holes of the apical parietal pleura: an unknown precursors of cervical lung hernia and association with primary spontaneous pneumothorax
44. Supplementary Methods, Tables 1 - 2, Figures 1 - 2 from Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
45. Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials
46. Chest wall resection and reconstruction for locally recurrent breast cancer: From technical aspects to biological assessment
47. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
48. Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study.
49. Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review
50. How Much Stress Does a Surgeon Endure? The Effects of the Robotic Approach on the Autonomic Nervous System of a Surgeon in the Modern Era of Thoracic Surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.